DM Clinical Research Seeks Children for Multiple Studies Including COVID-19 and Migraine

"There are many reasons parents elect to enroll children in clinical trials including access to vaccines that are not yet available to the general public, ...

March 26, 2023 | Sunday | News
Abcam's Rich Lane Talks Expansion in APAC Region

What are the major plans in store for the new APAC hub at Singapore? For a company like Abcam which strongly believes that collaboration is a big driver o...

March 26, 2023 | Sunday | Influencers
Enhanced traceability plays a crucial role in building a resilient biopharma supply chain

How do you foresee digitalisation trends in APAC pharmaceutical supply chain improvising visibility, agility, and business resilience?  Unpredict...

March 26, 2023 | Sunday | Influencers
Illumina and GenoScreen team up to combat Tuberculosis (TB) in Africa

Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, and GenoScreen, an innovative genomics company, have launched...

March 26, 2023 | Sunday | News
GENETWORx Looking to acquire or partner with Diagnostic Laboratories

GENETWORx is a clinical diagnostics laboratory based outside of Richmond, VA, that specializes in molecular pathogen and pharmacogenomic testing.  GEN...

March 18, 2023 | Saturday | News
AnPac Bio-Medical Science Announces US$5 Million Private Placement

AnPac Bio-Medical Science Co., Ltd. (Nasdaq: ANPC) ("AnPac Bio," the "Company" or "we"), a company with operations in the United States and ...

March 06, 2023 | Monday | News
Carina Biotech Receives FDA “Safe to Proceed” Letter

Receives greenlight from the FDA for Phase 1/2a clinical trial of CNA3103 On track to commence patient enrollment during the first half 2023 Carina B...

January 24, 2023 | Tuesday | News
LG Chem Completes Acquisition of AVEO Oncology

“We are excited to complete LG Chem’s acquisition of AVEO, which will position us to deliver on our mission of becoming one of the world’...

January 24, 2023 | Tuesday | News
AbbVie and Immunome Announce Strategic Collaboration to Discover Multiple Novel Oncology Targets

"Partnering with Immunome represents AbbVie's commitment to developing and commercializing novel treatment approaches for solid tumors," said Steve Davidse...

January 09, 2023 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close